Skip to content

Clinical study to assess the effect of Murvadi Agada in patients with Asthma caused due to Gara Visha (artificial poison)

Randomised controlled clinical trial to evaluate the efficacy of Murvadi Agada in Gara Vishajanya Tamaka Shwasa - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086891
Enrollment
60
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

None listed

Sponsors

Dr Yamini Vishwanath Chaudhari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of Gara vishajanya Tamak Shwasa belong to the age group of 18 to 60 years and all genders 2. Patients fulfilling the criteria of diagnosis will be selected for study 3. Patients will be selected irrespective of their gender, socioeconomic class, occupation etc.

Exclusion criteria

Exclusion criteria: 1.Below 18 years and above 60 Years 2. Acute Attack of asthma 3. URTI and LRTI 4. Asthma with cardiac and renal origin 5. Emphysema, Pleural effusion etc. 6 Severely ill patient e.g. TB., AIDS, STD, DM etc.

Design outcomes

Primary

MeasureTime frame
To access the efficacy of Murvadi Agada in Gara vishajanya Tamaka Shwasa w.s.r. to allergic bronchial asthemaTimepoint: Baseline, 15 days, 30 days

Secondary

MeasureTime frame
1. To collect all the literature of Gara Visha and its sources and effects in present era 2. To evaluate the effects of Gara Visha on body by pathological finding. 3. To find out the effect of therapies on lung functions 4. To establish a safe and economically, easily feasible drug treatment for Gara VishajanyaTamaka ShwasaTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Ashwini Patil

LRP Ayurvedic Medical College and Hospital Postgraduate Institute and Research Centre

drashwiniapatil@gmail.com9822735373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026